Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy of Type-5 Phosphodiesterase Inhibitors (Sildenafil and Vadenafil) in Primary and Secondary Pulmonary Hypertension

NCT00155714 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00155714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00155714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy of Type-5 Phosphodiesterase Inhibitors (Sildenafil and Vadenafil) in Primary and Secondary Pulmonary Hypertension
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
November 30, 2002
Completion date
May 31, 2005
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary and secondary pulmonary hypertension